• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Pleural Effusion (2010); Tachycardia (2095)
Event Date 07/06/2021
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient experienced a implantable cardioverter-defibrillator (icd) shock for atrial fibrillation with rapid ventricular response on (b)(6) 2021.The patient had a history of these issues and was started on amiodarone by drops.Cardioversion was also done and the patient was stable at the time.The patient experienced bilateral pleural effusions which were seen in chest x-ray on (b)(6) 2021.They had a moderate left and a small right pleural effusion.The patient remained in ongoing/stable condition.
 
Event Description
The patient's rapid ventricular response deteriorated into ventricular tachycardia.The patient was noted to have atrial fibrillation and implantable cardioverter-defibrillator prior to left ventricular assist device.The patient was discharged on (b)(6) 2021 on amiodarone 200 milligrams per day.An electrocardiogram on (b)(6) 2021 showed that the patient was in v-paced rhythm and biventricular pacemaker was detected.No further events were noted.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between the device and the reported cardiac arrhythmia and pleural effusions could not be conclusively established through this investigation.The patient remains ongoing on heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(6).No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on (b)(6) 2021.The heartmate 3 left ventricular assist system instructions for use lists cardiac arrhythmia as an adverse event, as well as a potential late postimplant complication that may be associated with the use of the heartmate 3 left ventricular assist system.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key12288845
MDR Text Key265420438
Report Number2916596-2021-04209
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/05/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8000642
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
Patient Weight90
-
-